Faulding Launches New Dosage Forms of Kadian Sustained-Released Morphine in the USA.Business/Health Editors NEW YORK--(BUSINESS WIRE)--March 15, 2001 International pharmaceutical and healthcare company, F H Faulding & Co Limited (Faulding) today announced that its Faulding Pharmaceuticals division has received FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval for additional dosage strengths of Kadian(R) brand sustained-release morphine sulphate product in the USA. Kadian competes in the sustained-release opioid market, valued at US$1.8 billion in the USA and growing at more than 60 per cent per annum Per annum Yearly. . Kadian has been marketed in the USA by Faulding Laboratories, the Company's branded pharmaceuticals business, since early 1998. Prescriptions of Kadian have grown by 180 per cent over the past year. Mr Frank Condella, President & Chief Executive Officer of Faulding Pharmaceuticals, said: "Kadian is positioned as the preferred oral sustained-release opioid due to the flexibility it offers in treating patients with moderate to severe chronic pain. It is the only sustained-release morphine sulphate product to be approved for once-daily administration, but may also be taken twice daily by patients preferring a more frequent dosage schedule. Kadian offers unique flexibility in administration, including sprinkle and gastronomy gastronomy Art of selecting, preparing, serving, and enjoying fine food. Two early centres of gastronomy were China (from the 5th century BC) and Rome, the latter noted for the excess and ostentation of its banquets. tube administration. The approval of the 30mg and 60mg capsules now provides patients with an expanded range of dosage options, further optimising the flexibility offered by Kadian." Faulding is a worldwide health and personal care company, listed on the Australian Stock Exchange Australian Stock Exchange (ASX) Australia's major securities market, formed when the six state stock exchanges (Adelaide, Brisbane, Hobart, Melbourne, Perth, and Sydney stock exchanges) were merged in 1987. . Faulding's principal businesses are oral and injectable in·ject·a·ble adj. Capable of being injected. Used of a drug. n. A drug or medicine that can be injected. pharmaceuticals, consumer health products, the provision of distribution and retail management services to pharmacies and logistics management Logistics Management is that part of Supply Chain Management that plans, implements, and controls the efficient, effective, forward, and reverse flow and storage of goods, services, and related information between the point of origin and the point of consumption in order to meet services to hospitals. Faulding products are sold in over 70 countries. KADIAN is a registered trade mark of F H Faulding & Co Limited. www.faulding.com/news |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion